×
S&P 500   3,860.50 (+0.76%)
DOW   31,143.64 (+0.57%)
QQQ   289.51 (+0.89%)
AAPL   143.35 (+1.26%)
MSFT   267.11 (+1.62%)
META   170.40 (+1.31%)
GOOGL   2,295.30 (+1.33%)
AMZN   115.09 (+1.40%)
TSLA   695.70 (-0.50%)
NVDA   152.27 (+1.76%)
NIO   20.70 (-6.67%)
BABA   118.95 (-0.98%)
AMD   75.68 (+0.64%)
MU   57.62 (+1.57%)
CGC   2.67 (-1.48%)
T   21.10 (-0.33%)
GE   61.68 (-0.56%)
F   11.11 (-0.80%)
DIS   96.43 (-0.77%)
AMC   12.54 (-1.88%)
PFE   52.50 (+1.67%)
PYPL   73.59 (-1.09%)
NFLX   185.07 (-0.44%)
S&P 500   3,860.50 (+0.76%)
DOW   31,143.64 (+0.57%)
QQQ   289.51 (+0.89%)
AAPL   143.35 (+1.26%)
MSFT   267.11 (+1.62%)
META   170.40 (+1.31%)
GOOGL   2,295.30 (+1.33%)
AMZN   115.09 (+1.40%)
TSLA   695.70 (-0.50%)
NVDA   152.27 (+1.76%)
NIO   20.70 (-6.67%)
BABA   118.95 (-0.98%)
AMD   75.68 (+0.64%)
MU   57.62 (+1.57%)
CGC   2.67 (-1.48%)
T   21.10 (-0.33%)
GE   61.68 (-0.56%)
F   11.11 (-0.80%)
DIS   96.43 (-0.77%)
AMC   12.54 (-1.88%)
PFE   52.50 (+1.67%)
PYPL   73.59 (-1.09%)
NFLX   185.07 (-0.44%)
S&P 500   3,860.50 (+0.76%)
DOW   31,143.64 (+0.57%)
QQQ   289.51 (+0.89%)
AAPL   143.35 (+1.26%)
MSFT   267.11 (+1.62%)
META   170.40 (+1.31%)
GOOGL   2,295.30 (+1.33%)
AMZN   115.09 (+1.40%)
TSLA   695.70 (-0.50%)
NVDA   152.27 (+1.76%)
NIO   20.70 (-6.67%)
BABA   118.95 (-0.98%)
AMD   75.68 (+0.64%)
MU   57.62 (+1.57%)
CGC   2.67 (-1.48%)
T   21.10 (-0.33%)
GE   61.68 (-0.56%)
F   11.11 (-0.80%)
DIS   96.43 (-0.77%)
AMC   12.54 (-1.88%)
PFE   52.50 (+1.67%)
PYPL   73.59 (-1.09%)
NFLX   185.07 (-0.44%)
S&P 500   3,860.50 (+0.76%)
DOW   31,143.64 (+0.57%)
QQQ   289.51 (+0.89%)
AAPL   143.35 (+1.26%)
MSFT   267.11 (+1.62%)
META   170.40 (+1.31%)
GOOGL   2,295.30 (+1.33%)
AMZN   115.09 (+1.40%)
TSLA   695.70 (-0.50%)
NVDA   152.27 (+1.76%)
NIO   20.70 (-6.67%)
BABA   118.95 (-0.98%)
AMD   75.68 (+0.64%)
MU   57.62 (+1.57%)
CGC   2.67 (-1.48%)
T   21.10 (-0.33%)
GE   61.68 (-0.56%)
F   11.11 (-0.80%)
DIS   96.43 (-0.77%)
AMC   12.54 (-1.88%)
PFE   52.50 (+1.67%)
PYPL   73.59 (-1.09%)
NFLX   185.07 (-0.44%)
NASDAQ:CTIC

CTI BioPharma Earnings Date, Estimates & Call Transcripts (2022)

$6.01
-0.24 (-3.84%)
(As of 07/6/2022 03:05 PM ET)
Add
Compare
Today's Range
$5.88
$6.31
50-Day Range
$3.55
$6.27
52-Week Range
$1.43
$6.52
Volume
338,109 shs
Average Volume
5.78 million shs
Market Capitalization
$654.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Earnings Summary

Upcoming
Earnings Date
Aug. 4Estimated
Actual EPS
(May. 12)
-$0.37 Missed By -$0.02
Consensus EPS
(May. 12)
-$0.35
Last Year's Q2 EPS
(6/1/2021)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data

CTIC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CTIC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CTI BioPharma Earnings Estimates

Current Year EPS Consensus Estimate: $-0.77 EPS
Next Year EPS Consensus Estimate: $0.42 EPS

CTIC Earnings Date and Information

CTI BioPharma last released its quarterly earnings data on May 12th, 2022. The biopharmaceutical company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.35) by $0.02. The firm had revenue of $2.30 million for the quarter, compared to the consensus estimate of $2.15 million. CTI BioPharma has generated ($1.22) earnings per share over the last year (($1.22) diluted earnings per share). Earnings for CTI BioPharma are expected to grow in the coming year, from ($0.77) to $0.42 per share. CTI BioPharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off prior year's report dates.

CTI BioPharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/4/2022
(Estimated)
        
5/12/2022Q1 2022($0.35)($0.37)($0.02)($0.37)$2.15 million$2.30 million
3/31/2022Q4 2021($0.28)($0.38)($0.10)($0.38)
11/12/2021Q3 2021($0.22)($0.26)($0.04)($0.26)
8/5/20216/30/2021($0.20)($0.21)($0.01)($0.21)    
6/1/20213/31/2021($0.22)($0.23)($0.01)($0.23)  
3/16/202112/31/2020($0.16)($0.20)($0.04)($0.20)    
11/15/20209/30/2020($0.15)($0.15)($0.15)    
8/6/2020Q2($0.1230)($0.19)($0.0670)($0.19)
5/7/2020Q1 2020($0.13)($0.20)($0.07)($0.20)
3/12/2020Q4 2019($0.2250)($0.14)+$0.0850($0.14)
11/4/2019Q3($0.23)($0.17)+$0.06($0.17)$2.29 million  
8/1/2019Q2 2019($0.19)($0.19)($0.19)$0.42 million  
5/2/2019Q1 2019($0.21)($0.19)+$0.02($0.19)$0.64 million
3/13/201912/31/2018($0.27)$0.01+$0.28$0.01$14.11 million  
11/1/20189/30/2018($0.20)($0.26)($0.06)($0.26)$0.60 million$0.72 million    
8/2/2018Q2 2018($0.23)($0.20)+$0.03($0.20)$0.30 million$0.61 million
5/3/2018Q1 2018($0.10)($0.08)+$0.02($0.08)$10.30 million$10.48 million  
3/7/2018Q4 2017($0.29)($0.33)($0.04)($0.33)$1.00 million$0.46 million    
11/6/2017Q3 2017($0.32)($0.28)+$0.04($0.28)$0.30 million$1.71 million
8/3/2017Q2 2017($0.60)$0.03+$0.63$0.03$22.23 million  
5/3/2017Q1 2017($0.70)($0.71)($0.01)($0.71)$0.75 million  
3/2/2017Q4 2016($0.70)($0.23)+$0.47($0.23)$9.14 million  
11/8/2016Q3 2016($0.70)($1.00)($0.30)($1.00)$4.43 million
8/4/2016Q2($0.10)($0.07)+$0.03($0.07)$7.36 million
5/10/2016Q1($0.04)$0.01+$0.05$0.01$36.48 million
2/16/2016Q4($0.18)($0.13)+$0.05($0.13)$11.32 million
11/5/2015Q315($0.12)($0.19)($0.07)($0.19)$18.89 million$1.00 million  
8/6/2015Q215($0.10)($0.19)($0.09)($0.19)$12.77 million$1.10 million  
5/6/2015Q115($0.14)($0.16)($0.02)($0.16)$9.84 million$2.73 million  
3/12/2015Q414($0.18)($0.27)($0.09)($0.27)$2.48 million$17.80 million  
10/29/2014Q3$0.03$0.03$0.03$21.52 million$39.53 million  
8/4/2014Q2($0.12)($0.19)($0.07)($0.19)$11.79 million$1.34 million  
4/29/2014Q114($0.20)($0.20)($0.20)$1.10 million$1.40 million
3/4/2014Q4 2013($1.50)$0.80+$2.30$0.80$1.26 million$32.90 million  
10/30/2013Q3 2013($1.70)($2.00)($0.30)($2.00)$2.00 million$0.36 million
7/31/2013Q2 2013($1.70)($1.70)($1.70)$1.50 million$0.31 million
5/2/2013Q1 2013($4.40)($1.80)+$2.60($1.80)$1.13 million
2/28/2013Q4 2012($0.20)($0.20)$1.00 million  
11/1/2012Q312($0.38)($0.38)
8/1/2012Q2 2012($7.15)($7.15)($0.30)
4/20/2012Q1 2012($5.00)($4.30)+$0.70($4.30)
3/7/2012Q4 2011($4.00)($7.40)($3.40)($10.30)
10/25/2011Q3 2011($5.50)($8.00)($2.50)($8.00)
7/28/2011Q2 2011($6.00)($6.80)($0.80)($6.80)
4/27/2011Q1 2011($6.00)($17.40)($11.40)($17.40)
2/16/2011Q4 2010($6.00)($12.00)($6.00)($12.00)
10/28/2010Q3 2010($18.00)($6.60)+$11.40($6.60)
8/5/2010Q2 2010($6.00)($23.10)($17.10)($21.90)
4/28/2010Q1 2010($22.20)($22.20)($22.20)
2/11/2010Q4 2009($9.00)($14.40)($5.40)($14.40)
11/5/2009Q3 2009($27.89)($27.89)($27.89)
8/6/2009Q2 2009($15.00)($15.30)($0.30)($12.30)
5/7/2009Q1 2009($80.98)($26.99)+$53.99($36.28)
3/16/2009Q4 2008($287.94)($162.57)+$125.37($170.37)
11/7/2008Q3 2008($1,019.80)($850.03)+$169.77($850.03)
8/18/2008Q2 2008($1,049.79)($1,406.72)($356.93)($1,259.75)
5/8/2008Q1 2008($1,409.72)($2,303.54)($893.82)($2,303.54)
3/13/2008Q4 2007($1,649.67)($2,231.55)($581.88)($2,231.55)












CTI BioPharma Earnings - Frequently Asked Questions

When is CTI BioPharma's earnings date?

CTI BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off last year's report dates. Learn more on CTIC's earnings history.

Did CTI BioPharma beat their earnings estimates last quarter?

In the previous quarter, CTI BioPharma (NASDAQ:CTIC) missed the analysts' consensus estimate of ($0.35) by $0.02 with a reported earnings per share (EPS) of ($0.37). Learn more on analysts' earnings estimate vs. CTIC's actual earnings.

How much revenue does CTI BioPharma generate each year?

CTI BioPharma (NASDAQ:CTIC) has a recorded annual revenue of $3.35 million.

How much profit does CTI BioPharma generate each year?

CTI BioPharma (NASDAQ:CTIC) has a recorded net income of -$97.91 million. CTIC has generated -$1.22 earnings per share over the last four quarters.

What is CTI BioPharma's EPS forecast for next year?

CTI BioPharma's earnings are expected to grow from ($0.77) per share to $0.42 per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CTIC) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.